preprint
<title>Abstract</title> A 95-day feeding trial was conducted to evaluate the outcomes of feeding <italic>Bacillus subtilis</italic> fermented <italic>Azolla (BSFA)</italic> on nonspecific immunity, antioxidative status, intestinal digestive enzymes and histomorphometry, and disease resistance in the Nile tilapia. We formulated five isonitrogenous and isocaloric experimental diets to incorporate <italic>BSFA</italic> at (0%, 15%, 30%, 45%, 60%). The growth performance parameters (<italic>FBW, BWG, SGR, PER</italic> and <italic>FCR</italic>) revealed a significant increase in the <italic>BSFA30</italic> tilapia group compared to the control group followed by <italic>BSFA45</italic> (<italic>P < 0.05</italic>). The <italic>BSFA30</italic> group exhibited the highest nonspecific immunity parameters (lysozyme activity, phagocytic index and phagocytic activity) compared to other groups (<italic>P < 0.05</italic>). SOD and GPx reported the highest values in the <italic>BSFA60</italic> group. Nile tilapia carcass composition was not influenced by <italic>BSFA</italic> inclusion level (<italic>P ˃ 0.05</italic>). Interestingly, Nile tilapia fed with <italic>BSFA15 </italic>diet exhibited the highest protease activity level <italic>(P </italic>˂<italic> 0.05)</italic>, while those fed on <italic>BSFA30 </italic>documented the highest amylase activity. Intestinal histomorphology was significantly enhanced with the gradual increase of administrated <italic>BSFA</italic>. Tilapia disease resistance against <italic>A. septicemia</italic>, <italic>BSFA </italic>significantly diminished the cumulative mortality compared to the control group. To sum up, <italic>BSFA</italic> was more effective in improving the growth performance and immunity of Nile tilapia.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21203/rs.3.rs-1119713/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.